Recent studies also testified that METTL3-mediated m6A modification of TIMP2 can enhance podocyte injury in DN [14]; METTL3 can attenuate renal injury and interstitial fibrosis by enhancing NSD2 stability [15]. The gene discussed is METTL3; the disease is liver dysplastic nodule.